Sentence examples for trials to interpret from inspiring English sources

Nevertheless, to understand the impact of disease activity on the vast arrays of outcomes in RA, to select patients for clinical trials, to interpret laboratory findings or results from basic scientific investigations, to judge the indication or the necessity to change therapy, and to define the most appropriate therapeutic aims, categorical criteria are helpful.

This makes the results of individual trials difficult to interpret and the comparison of multiple trials impossible.

First, to make results from various trials easier to interpret, the language and conduct of clinical trials needs to improve.

The lack of radiological staging and the different TNM system in the trial (UICC 1985), based on anatomical extent, rather than size, make comparisons with modern trials difficult to interpret.

A large number of laser parameters available in treatment may make comparison between trials difficult to interpret.

Meanwhile it seems prudent to encourage independent validation of the current data in other large randomized clinical trials and to interpret the prognostic significance of IHC detection of p53 in the context of ER expression.

WHAT THIS STUDY ADDS TO OUR KNOWLEDGE ☑ This study describes the PK/PD characteristics of lampalizumab, which is critical to help guide the rational design of phase III trials and to interpret the safety and efficacy data in patients with GA.

The most effective treatment for PSA-detected localised prostate cancer is also unknown because treatment within published screening trials was not randomised, and published treatment trials are difficult to interpret in relation to screening and the known heterogeneity of the disease.

Assessment criteria often vary between trials, making some cross-trial comparisons difficult to interpret.

The results of such trials are difficult to interpret because of the small numbers of events that occur in each; interpretation may be facilitated by pooling the data from all the relevant trials when these are fully adjudicated and are made publicly available.

The data from the ESPAC trial are difficult to interpret as the design of the trial allowed not only for randomisation between chemoradiation and observation but also a separate randomisation according to physician preference, for chemotherapy only, chemoradiation, or observation.